Astera Labs, Inc. — Director's Dealing 2024

Aug 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Astera Labs, Inc. (ALAB)
CIK: 0001736297
Period of Report: 2024-08-13

Reporting Person: Tate Michael Truett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-13	Common Stock	A	74976	—	Acquired	1340823	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	879108	Indirect

Footnotes

F1: These shares represent an award of restricted stock units ("RSUs") granted on August 13, 2024 (the "Grant Date") under the Astera Labs, Inc. Amended and Restated 2024 Stock Option and Incentive Plan. Such award which provides that the RSUs shall vest as to 25% on August 15, 2025 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F2: The Form 4 filed by the Reporting Person on March 22, 2024 inadvertently aggregated the direct and indirect amounts beneficially owned, which has been updated to reflect the correct amount owned by the Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust").

F3: These shares are owned directly by Tate Trust, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.